Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Solace Health, a company that connects patients with an "advocate" to help them navigate the U.S. healthcare system after a diagnosis, announced on Tuesday that it's earned $130 million in Series C funding, bringing its valuation to the coveted “unicorn status."
The insurer said Google’s Gemini was part of the new AI’s core development. The system will support customer service interactions by automatically summarizing calls and pulling up relevant information, without the need for manual input. The Google Cloud will be providing the necessary data security to ensure patient privacy, the companies added.
A report from Gibbins Advisors found that, overall, the healthcare space is feeling the stress of economic chaos, including Medicaid cuts, tariffs and high interest rates.
The new tool received $25,000 in funding after winning the grand prize in a Veterans Day pitch contest. Currently in a pilot phase, the website will help troops find shelter, be it temporary or permanent.
Radiology researchers from six leading medical schools have laid out some attuned and readily adoptable strategies for groups challenged to prosper in a time of difficult reimbursement dynamics.
An AI startup has received the FDA’s go-ahead to market a new tool within its existing platform that automatically diagnoses stroke and brain injury in hyperdense brain tissue imaged with unenhanced CT.
A Canadian manufacturer of positron emission tomography equipment has received FDA’s OK to market a small-footprint scanner that images targeted organs bearing radiotracers at close range.
A global tech and pharma vendor is set to inject U.S. healthcare with a set of generic contrast agents, the first of which will be an FDA-approved substitute for GE Healthcare’s Visipaque.
A healthcare AI startup in Silicon Valley is partnering with a top-tier medical school—and hopefully a few good radiologists—to test a hypothesis that’s increasingly crucial to radiology.